| Novartis Pharma Schweiz AG - Azarga, Augentropfensuspension | | 59179 | | 01 | | Azarga | | Augentropfensuspension | | S01ED51 | | Timolol, Kombinationen | | 25.03.2009 | | |
| | Composition | | brinzolamidum 10 mg, timololum 5.0 mg ut timololi maleas, dinatrii edetas, natrii chloridum, mannitolum, tyloxapolum, carbomerum 974P, benzalkonii chloridum 0.1 mg, acidum hydrochloridum aut natrii hydroxidum, aqua purificata, ad solutionem pro 1 ml. | | Packungsbestandteile | | Augentropfensuspension | | | | | | | | Principe actif | Concentr. |
|---|
| Brinzolamide | 10 mg/ml | | Timolol | 5 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Brinzolamide | 10 mg | | Timolol | 5 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum aut Natrii Hydroxidum | | | Aqua Purificata | | | Benzalkonium Chlorure | 0.1 mg/ml | | Carbomerum 974P | | | Dinatrii Edetas | | | Mannitol | | | Sodium Chlorure | | | Tyloxapolum | |
| |
| |
|
